Chemoinformaics analysis of Picropodopyllotoxone
| Molecular Weight | 412.394 | nRot | 4 |
| Heavy Atom Molecular Weight | 392.234 | nRig | 25 |
| Exact Molecular Weight | 412.116 | nRing | 5 |
| Solubility: LogS | -4.707 | nHRing | 2 |
| Solubility: LogP | 2.415 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 50 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 30 | No. of Aromatic Carbocycles | 2 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 12 |
| nHA | 8 | APOL | 56.4919 |
| nHD | 0 | BPOL | 32.2161 |
| QED | 0.672 |
| Synth | 3.331 |
| Natural Product Likeliness | 1.172 |
| NR-PPAR-gamma | 0.46 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.059 |
| Pgp-sub | 0.199 |
| HIA | 0.004 |
| CACO-2 | -5.008 |
| MDCK | 0.0000427 |
| BBB | 0.035 |
| PPB | 0.876518 |
| VDSS | 0.716 |
| FU | 0.0875802 |
| CYP1A2-inh | 0.334 |
| CYP1A2-sub | 0.976 |
| CYP2c19-inh | 0.178 |
| CYP2c19-sub | 0.829 |
| CYP2c9-inh | 0.066 |
| CYP2c9-sub | 0.77 |
| CYP2d6-inh | 0.255 |
| CYP2d6-sub | 0.876 |
| CYP3a4-inh | 0.525 |
| CYP3a4-sub | 0.36 |
| CL | 6.963 |
| T12 | 0.559 |
| hERG | 0.046 |
| Ames | 0.59 |
| ROA | 0.07 |
| SkinSen | 0.298 |
| Carcinogencity | 0.408 |
| EI | 0.022 |
| Respiratory | 0.901 |
| NR-Aromatase | 0.823 |
| Antiviral | Yes |
| Prediction | 0.850001 |